Watch CNBC's full interview with Eli Lilly CEO David Ricks

David Ricks, Eli Lilly chair and CEO, joins 'Closing Bell Overtime' to talk the FDA's approval of its new weight-loss drug, keeping up with demand for the drug, competition in the space and more.